Inventor · disambiguated record
Christopher Dufton
Also filed as: DUFTON CHRISTOPHER
7 granted patents·4 pending applications·17 citations·filing 2007–2023
80Inventor score
Files withGILEAD SCIENCES INC3ARCA BIOPHARMA INC2GERBER MICHAEL J2GILEAD COLORADO INC2GENVARA BIOPHARMA INC1
Top patents by PatentIndex Score
11 records- 0187US8377933B2Method for treating a pulmonary hypertension conditionGILEAD COLORADO INC·Filed 2011·Granted Feb 19, 2013·13 cites·11 claims
- 0281US9504685B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·2 cites·6 claims
- 0378US9474752B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2014·Granted Oct 25, 2016·2 cites·15 claims
- 0472US12491177B2Methods and compositions involving bucindolol for the treatment of atrial fibrillationGENVARA BIOPHARMA INC·Filed 2023·Granted Dec 9, 2025·0 cites·19 claims
- 0572US11554107B2Methods and compositions involving bucindolol for the treatment of atrial fibrillationARCA BIOPHARMA INC·Filed 2021·Granted Jan 17, 2023·0 cites·20 claims
- 0669US10925856B2Methods and compositions involving bucindolol for the treatment of atrial fibrillationARCA BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·0 cites·24 claims
- 0764US9993475B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2016·Granted Jun 12, 2018·0 cites·6 claims
- 0863US2008139593A1Method for treating a pulmonary hypertension conditionGERBER MICHAEL J·Filed 2007·Application pending·0 cites
- 0960US2025332152A1Inhaled therapy for cardiac arrhythmiaINCARDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1057US2013116257A1Method for treating a pulmonary hypertension conditionGILEAD COLORADO INC·Filed 2012·Application pending·0 cites
- 1153US2010152217A1Method for treating a pulmonary hypertension conditionGERBER MICHAEL J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Dufton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →